SAM
RYTM icon

Smartleaf Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Smartleaf Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Hold
264
– – ﹤0.01% 1813
2026
Q1 		$20.4K Sell
264
-135
-34% -$13.1K ﹤0.01% 1944
2025
Q4 		$42.6K Buy
399
+113
+40% +$12K ﹤0.01% 1631
2025
Q3 		$28.8K Buy
286
+141
+97% +$13.1K ﹤0.01% 1660
2025
Q2 		$9.1K Sell
145
-110
-43% -$6.74K ﹤0.01% 1855
2025
Q1 		$14K Buy
255
+62
+32% +$3.44K ﹤0.01% 1783
2024
Q4 		$10.9K Buy
193
+73
+61% +$4.03K ﹤0.01% 1956
2024
Q3 		$6.16K Buy
120
+107
+823% +$5.13K ﹤0.01% 2026
2024
Q2 		$521 Buy
+13
New +$519 ﹤0.01% 2546

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Smartleaf Asset Management's RYTM Position: Q2 2026 in Review

Smartleaf Asset Management held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 264 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Smartleaf Asset Management first reported a position in RYTM in Q2 2024 and has held it in 9 quarters since. The position peaked at $42.6K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Smartleaf Asset Management held 264 shares of Rhythm Pharmaceuticals worth $29.1K as of Q2 2026.
  • Smartleaf Asset Management left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1813 holding.
  • Smartleaf Asset Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Rhythm Pharmaceuticals position peaked at $42.6K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.